KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Non-Current Debt (2017 - 2025)

Astrana Health's Non-Current Debt history spans 12 years, with the latest figure at $403.9 million for Q1 2025.

  • For Q1 2025, Non-Current Debt rose 9.62% year-over-year to $403.9 million; the TTM value through Mar 2025 reached $403.9 million, up 9.62%, while the annual FY2024 figure was $425.3 million, 64.25% up from the prior year.
  • Non-Current Debt for Q1 2025 was $403.9 million at Astrana Health, down from $425.3 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $425.3 million in Q4 2024 and bottomed at $182.7 million in Q2 2021.
  • The 5-year median for Non-Current Debt is $205.7 million (2023), against an average of $267.3 million.
  • The largest annual shift saw Non-Current Debt decreased 20.72% in 2021 before it soared 107.18% in 2024.
  • A 5-year view of Non-Current Debt shows it stood at $182.9 million in 2021, then increased by 11.19% to $203.4 million in 2022, then increased by 27.31% to $258.9 million in 2023, then surged by 64.25% to $425.3 million in 2024, then dropped by 5.03% to $403.9 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Non-Current Debt are $403.9 million (Q1 2025), $425.3 million (Q4 2024), and $423.1 million (Q3 2024).